receptor^.^'^ The a chain confers specificity to the receptor,' while the Pc chain is involved in signal transdu~tion.',~ GMR is expressed on myeloid cells throughout their maturational ~e q u e n c e .~.~ The receptor mediates proliferation of immature myeloid cells' and stimulation of mature cell types (neutrophils [PMN] and monocytes/ma~rophages).~~'~ Because of these properties, GM-CSF is being used in vivo to aid bone marrow reconstitution following cancer therapy and to enhance neutrophiVmacrophage function. I I"* Although GM-CSF has been widely used in the treatment of B-cell malignan~ies,l~-'~ little is known about the potential effects of GM-CSF on B ~e l l s . '~, '~ In this report, we have used specific monoclonal antibodies (MoAbs) to both chains of the GM-CSF receptor to examine receptor expression in hairy cells (HCs) and other cells of the B-cell lineage. We found that GMR expression is a stage-specific feature of late B cells. Further, we show that in HCs GM-CSF inhibits motility and adhesion without affecting a range of other functions. We suggest that these observations indicate that GM-CSF is important in the tissuephase migration of HCs and that similar mechanisms may be involved in normal B-cell development.
MATERIALS AND METHODS

Cell Sources
Patients. Cells from six patients with hairy cell leukemia (HCL) were examined: all the patients had entirely typical disease morphologically, histologically, and immunophenotypically . '* Peripheral blood mononuclear (PBM) cells were used from four of the cases, whereas in the other two, splenic lymphocytes were employed.
Peripheral blood was examined from eight cases of chronic lymphocytic leukemia (CLL), two cases of prolymphocytic leukemia (PLL), and one case of plasma-cell leukemia; in addition bone marrow was used from four cases of multiple myeloma. Normal B receptor is therefore stage specific, rather than a feature of activation. Perhaps, surprisingly, in view of its effects on myeloid cells, GM-CSF did not stimulate the proliferation or differentiation of HCs and did not protect them from apoptosis. However, the cytokine had a profound effect on the interaction of the HC with its environment. Thus, the cytokine caused a major cytoskeletal reorganization resulting in the inhibition of motility and loss of adhesion to cellular and matrix ligands. These studies indicate the importance of GM-CSF outside myelopoiesis and demonstrate a previously unrecognized stage specific role for the cytokine in B-cell biology. Taken together with our previous report that M-CSF enhances B-cell motility, the present findings indicate that myeloid growth factors act in concert to facilitate the controlled migration of certain B cells into and within tissues. 0 1996 b y The American Society of Hematology. lymphocytes were derived from peripheral blood (n = 3) or tonsil (n = 4).
Cell Preparation
PBM cells were isolated by ficol-hypaque (F/H) density gradient centrifugation. Tissue from spleen and tonsil was dispersed through a wire mesh before F/H centrifugation. Where T cells formed >5% of PBM, they were removed before culture using 2-aminoethylisothiouronium bromide (AET)-treated sheep erythrocyte (SRBC) rosetting.
Normal B lymphocytes were purified from tonsil and peripheral blood by two rounds of SRBC rosetting to remove T lymphocytes; monocytes were then removed by plastic adherence. The resulting populations contained >95% CDI 9-positive B lymphocytes. The tonsil B cells were then separated further into their low-density (activated; CD25 > 80%) and high density (resting; CD25 < 10%) components by density gradient centrifugation over 60% percol.'' Plasma cells were purified from tonsil mononuclear cells using one round of SRBC rosetting followed by depletion of remaining CD3-, CD14-, and CD19-positive cells using magnetic beads coated with sheep antimouse immunoglobulin. Plasma-cell populations purified in this way were >95% CD38 positive.
Human endothelial cells (HUVE) were obtained from umbilical cords.'" Briefly, the umbilical vein was filled with phosphate-buffered saline (PBS) containing 0.17% trypsin and detached endothelid cells removed by flushing with PBS. The HUVE were then washed and cultured as described below.
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Cell Culture
Lymphocyte cultures were performed in RPMI 1640 medium containing 100 U/mL penicillidstreptomycin, 100 pg/mL L-glutamine and 10% fetal calf serum (complete medium) and incubated at 37°C in 5% C 0 2 in air.
HL60 cells were kept in continuous culture in complete medium and subcultured twice a week.
HUVE were cultured to confluence in Iscove's modified minimal essential medium (IMEM) containing 20% fetal calf serum, 100 U/ mL penicillidstreptomycin, and 100 pg/mL L-glutamine. HUVE were used at first passage.
All B-cell cultures were performed in complete medium at a cell concentration of 2 X 106/mL (except where stated).
Effect of Cytokines on GMR Expression
GMR expression by HCs was measured after 4, 24, and 48 hours of culture in the presence of GM-CSF at 0.1, 1, and 10 ng/mL, or IL-2 at 100 UlmL. Normal tonsil B cells were stimulated with 0.001% SAC plus 100 U/mL IL-2; GMR expression was examined on these cells at 4, 24, and 48 hours.
Cytokines and MoAbs
The following cytokines were used: GM-CSF, LL-3, IL-6 (Sandoz, Leeds, UK); tumor necrosis factor a (TNFa; Knoll, Munich, Germany); IL-2 (Sigma, Poole, UK); and M-CSF (Eurocetus; Harefield, UK). In certain experiments, the polyclonal B-cell activator SAC (Sigma) was also employed.
MoAbs 
Immunophenotyping
Because levels of cytokine receptor expression are generally low, three-layer immunofluorescence was used to identify cells expressing GMR. 24 Briefly, cells were incubated with the GMR a and MoAbs at 100 pg/mL, followed by donkey antimouse biotin at 50 pg/mL (Vector Labs, Petersborough, UK), and finally with streptavidin-phycoerythrin diluted 1 :5 (Becton Dickinson). These antibody concentrations had been found to produce optimal staining on control HL60 cells.
Other surface antigens were detected with indirect immunofluorescence employing goat antimouse fluorescein isothiocyanate (FITC) as second layer. Both first-and second-layer antibodies were used at saturating concentrations. Cells were analyzed on a FACS analyzer I using a Consort 30 computer (Becton Dickinson).
Alkaline phosphatase anti-alkaline phosphatase (APAAP). In selected experiments, this techniquez5 was used to demonstrate GMR positivity. Also, the method allowed morphological identification of GMR-positive cells and confirmation of the plasma-cell nature of certain positive cells in tonsil (using a MoAb to the rough endoplasmic reticulum, RFD6).
For all three staining methodologies, the appropriate class-specific control IgGl and IgG2 were used.
Fluorescence-activated cell sorter.
Binding Studies
To confirm the antibody data for GMR expression, binding studies using radiolabelled (Iz5I) GM-CSF were performed according to the method of Woodcock et aL2* Briefly, HCs were incubated for 2 hours with 0.1, 0.5, I , 5, or 10 ng/mL of '"I-GM-CSF (DuPont, Wilmington, DE) in the presence or absence of 1 pglmL of unlabelled GM-CSF. Cell-associated radioligand was separated from free radioligand by overlaying the cell suspension on pthalate oil and centrifuging for 2 minutes at 13,000 rpm in a microfuge. The cell pellet was then removed by cutting, and radioactivity was measured using a gamma counter. Receptor number and dissociation constants were determined using Schatchard analysis.
Functional Effects of GM-CSF on HCs
HCs were incubated in the presence and absence of GM-CSF at 1, 10, and 100 ng/mL, with or without the following cytokines; IL-3 (1, 10, and 100 nglmL), IL-6 ( I , 50, and 100 U/ mL), M-CSF (100 and 1,000 UlmL), and TNFa (100 and 1,000 U/ mL). IL-6 was used because studies on myeloma have shown that proliferation induced by IL-6 was enhanced by GM-CSF." M-CSF and TNFa were used because they synergize with GM-CSF on myeloid cells and because TNFa is a known growth factor for HCszh; IL-3 was used because it shares the pc chain with GM-CSF? Proliferation, measured by tritiated thymidine incorporation, was examined at 3, 6 , 9, and 12 days.
As a measure of differentiation, immunoglobulin secretion by HCs was determined. Supernatants were collected from HCs cultured for 10 days in the presence or absence of GM-CSF at I , IO, and 100 ng/mL. Levels of secreted IgG and IgM were then measured using enzyme-linked immunosorbent assay (ELISA)." Tonsil B cells were incubated with SAC (0.001%) plus 1L-2 (100 U/mL) as a positive control for the detection of immunoglobulin secretion.
HCs were incubated in the presence or absence of GM-CSF at 0.1, 1, and 10 ng/mL and examined at 30 minutes, I , 4, 24, and 48 hours, using MoAbs against the following antigens; CD I 1 b, CD 19, CD25, K and h. Justification for the use of these antibodies is given in the Results.
The survival of HCs in vitro is dependent on cell number, with HCs undergoing markedly increased apoptosis at densities below 1 X 105/mL. HCs were therefore seeded at a range of concentrations between 2 X IOh and 2 X 104/mL in complete medium in the presence and absence of GM-CSF at 1, 10, and 100 ng/mL for 2 days. HCs were then harvested and propidium iodide (PI) (a vital dye) added. HCs were then assayed for apoptosis by fluorescence-activated cell sorter (FACS) analysis; dead cells formed a population of cells distinguishable by their increased uptake of PI and their decreased size. To show that cell death was indeed due to apoptosis, HCs were incubated as above and stained using hypotonic PI.2R Apoptotic HCs formed a marked sub-GI population on the FACS histogram.
Cell motility. Briefly, glass cover slips were coated overnight with either vitronectin or fibronectin at 20 pg/mL and washed. The coverslips were then placed in 24-well plates together with 1 X IO' HCs in RPMI and incubated for 90 minutes. GM-CSF ( I O ng/mL) was then added for I , 5, and I O minutes. The effects of the cytokine were arrested by adding glutaraldehyde, and the coverslips thoroughly washed, allowed to dry, and stained with Harris' hematoxylin.
The cells were examined microscopically and then analyzed in an objective, quantitative manner by image analysis. Area, length, circularity, and perimeter of HCs proved useful measures of the changes observed in the presence GM-CSF. The statistical significance of differences observed between treated and control cultures was then calculated using analysis of variance.
Chemotaxis/chemokinPsis. Nitrocellulose filters were coated overnight with 20 pg/mL of vitronectin or fibronectin and washed in PBS. GM-CSF at 0.01, 0.1, 2, 10, and 100 ng/mL was added to the HCs in the top chamber and the chamber incubated at 37°C for 90 minutes. The filter was then fixed with paraformaldehyde, stained Proliferation.
LXferentiafion.
Antigen expression.
Apoprosis.
For personal use only. on April 10, 2017. by guest www.bloodjournal.org From Abbreviation: ND, not done.
* The mean fluorescence of positive cells expressed in arbitrary units.
t Because the reactivity of all the HCs was shifted to the right relative to the control (Fig I) , they were considered to be 100% positive.
*The FACS peaks for these cells could be superimposed on the isotypic control peaks.
5 In these patients, myeloma PCs could only be enriched to a maximum of 80% purity and, because contaminating cells were not distinguishable on the basis of volume/light scatter, examination was performed by APAAP rather than by FACS. PCs were identified by both morphology and by staining for the PC antigen RFD6.
11 In these patients, highly pure (>95%) PCs were obtained, and the analysis was therefore performed by FACS. In both FACS and APAAP preparations, a minority of PCs were clearly negative (cf. HC populations).
with hematoxylin, washed, and then clarified with xylene. The movement of the leading front of cells was measured. In addition, to establish the relative roles of chemotaxis versus chemokinesis, checkerboard analysis was performed; GM-CSF was added above, below, or on both sides of the filter, and the assay performed as above.
"S-methionine-labeled HCs were incubated on fibronectin-or vitronectin-coated plates or on HUVE for 90 minutes.
GM-CSF (10 ng/mL) was added and the cells incubated for a further 1, 10, or 30 minutes. After washing, the cells were trypsinized to ensure all HCs were harvested. The harvested radioactivity provided a measure of adherent cells. 
Adhesion.
RESULTS
HCs Possess Receptors for GM-CSF
HCs were shown to express both the a and pc chains of the GMR in all six cases studied ( Table 1 ). The fact that there was a unimodal distribution of fluorescent HCs, which was shifted to the right relative to the isotypic control, indicates that all HCs were positive (Fig 1) %; this was confirmed by APAAP staining (n = 3, data not shown). pmol/L (n = 1).
To determine whether the expression of receptor by HCs is a feature of differentiation or activation, we examined a range of other lymphoproliferative disorders of differing maturity, together with resting and activated normal B cells.
GMR Expression by Other Neoplastic B-Cell Types
Expression of the GMR was not seen on the B cells of either CLL (eight cases) or PLL (two cases) ( Table 1) . Expression of both chains of the GMR was, however, consistently demonstrable on the plasma cells of multiple myeloma (six of six positive) and of plasma cell leukemia (one case) ( Table 1) ; positivity was observed by both FACS and APAAP.
GMR Expression by N o m 1 B Cells
Purified peripheral blood B cells did not express GMR (three of three cases; data not shown). In purified tonsil Bcell preparations, a variable but small number of cells (up to 10%) were positive, while most lacked receptor (data not shown). For personal use only. on April 10, 2017. by guest www.bloodjournal.org From When the tonsil B cells were separated into low-and highdensity fractions (respectively containing higher and lower percentages of CD2S-positive, activated lymphocytes) both populations contained a similar number (up to 10%) of GMR-positive cells, despite differing greatly in their activation state (Table 2) . Furthermore, when the high-density tonsil B cells were activated with SAC plus IL-2 for up to 48 hours, no increased GMR expression was observed, despite marked increases in the levels of CD2S (Table 2) .
We next examined the morphology of the GMR-positive cells in APAAP-stained tonsil preparations; the GMR-positive cells resembled PCs. When the PCs in these tonsil preparations were enriched by depletion of CD19+ B cells, the cells were GMR positive by both FACS and APAAP; their plasma cell nature was confirmed morphologically and by APAAP staining for RFD6 ( Table 2) .
Regulation of GMR Expression on HCs
GM-CSF is known to downregulate its receptor on myeloid cell^.^^^" To determine whether or not this was so for B cells and to establish whether the receptor was active, regulation of GMR on HCs in response to GM-CSF was examined. Culture of HCs with the cytokine caused downregulation of both the a and pc (Fig 2) chains of the GMR (three of three cases). Reduced receptor expression was most marked at 24 hours, and had retumed to prestimulation levels by 48 hours (Fig 2) .
HCs were incubated with IL-2 to ensure that the downregulation of GMR expression in response to GM-CSF was specific (HCs express all three chains of the IL-2 recepto82). IL-2 at IO0 U/mL had no effect on HC GMR expression at 4, 24, and 48 hours (n = 3, data not shown).
GM-CSF Has no Effect on the Proliferation/ DifferentiatiodSurvival of HCs
Culture of HCs for up to 12 days in the presence of GM-CSF did not induce HC proliferation (three
Proliferation.
of three cases; data not shown). Because costimulation with other cytokines enhances the proliferation of myeloid cells induced by GM-CSF,33 the effects on HCs of costimulation with various other cytokines were also investigated. As expected,26 TNFa induced HC proliferation; however, GM-CSF had no additional effect (three of three cases; data not shown). M-CSF, IL-3, and IL-6 had no influence on HC proliferation; GM-CSF did not synergize with these growth factors (three of three cases; data not shown).
This was assessed by both immunoglobulin production and immunophenotypic analysis. After 10 days' culture, HCs produced only background levels of immunoglobulin secretion (<0.03 ng/mL IgG and IgM). Culture with GM-CSF in the presence and absence of IL-6 had no effect on immunoglobulin secretion (data not shown).
Incubation of HCs with GM-CSF did not induce any consistent changes in the expression of CD1 lb, CD19, CD25, K or A during 4 days of culture (data not shown). These antigens were chosen either because they are markers of Bcell differentiation/activation (CDI 9, CD25, K/A) or because GM-CSF is known to alter their expression on myeloid cells HC survival declined after a 48-hour culture, and the morphological features of cell death by apoptosis were observed. Cell death occurred at all the cell densities tested, but was most marked at low seeding concentrations ( 5 1 X I05/mL). In selected experiments, cell death was formally shown to be the result of apoptosis by FACS analysis of cellular DNA content. GM-CSF, over a range of concentrations, had no effect on survivallapoptosis, regardless of the density of HCs (data not shown).
Differentiation. (CDI 1b).34.35
Survival.
GM-CSF Inhibits the Motility of HCs
HCs respond differently to different substrata; on vitronectin, they adopt a polarized morphology indicative of cell movement." GM-CSF caused HCs to lose this polarity and, within 1 minute, to take on a rounded, unspread appearance. These morphological changes were confirmed by image analysis, where the rounding up was reflected in increased cell circularity and decreased cell area, length, and perimeter ( P < .01) (Fig 3) . A neutralizing anti-GM-CSF MoAb abrogated these effects, whereas treatment with an irrelevant MoAb (against IL-I@) had no effect (data not shown).
HCs migrate spontaneously into filters coated with vitronectin or fibronectin." GM-CSF inhibited this movement, whether present on either or both sides of the filter; this inhibition was dose-dependent (Table 3 ). These results indicate that the cytokine inhibits cell movement and is not chemotactic.
GM-CSF Inhibits the Adhesion of HCs
HCs adhere to both fibronectin-and vitronectin-coated surfaces. On fibronectin, they display a spread (nonpolar), adherent a p p e a r a n~e .~~ GM-CSF caused the HCs to become less spread and, within 10 minutes, many of the cells had detached. These morphological changes were confirmed by image analysis (data not shown), and the effects were blocked with a neutralizing anti-GM-CSF MoAb.
For In an adherence assay, addition of GM-CSF to HCs adherent to either fibronectin or vitronectin caused a rapid (within 1 minute) reduction in adherence, and the cells did not reattach after up to 30 minutes of culture ( Table 4) .
HCs also adhere to endothelial cells in vivo and in vitro, and this adhesion provides a proliferative
We therefore investigated the effects of GM-CSF on HC adhesion to endothelium. After a 10-minute incubation with the cytokine, the number of HCs adherent to HUVE was markedly reduced (control loo%, GM-CSF 32% 2 3%; n = 3).
Changes Induced by GM-CSF Are Accompanied by Cytoskeletal Reorganization, but not by Altered Integrin Expression
The decrease in HC adhesion to HUVE and matrix proteins was not due to changes in integrin expression. Thus, both short (1 to 30 minutes) and longer term (4 to 24 hours) culture with GM-CSF did not alter the expression of the a4, 0 5 , aM, P l , and p3 integrin chains on HCs (data not shown).
GM-CSF, however, rapidly reduced the amounts of polymerized actin in HCs (Fig 4) . This decrease was evident after 1 minute of incubation with the cytokine and persisted for 5 minutes; levels returned to those of the control HCs by 10 minutes. No further changes were seen after this time point. 
DISCUSSION
The present study clearly demonstrates that HCs express both the CY and ,Bc chains of the GMR. Some of the features of HCs reflect their stage of maturation, while others relate to their state of a~tivation.~"~' We therefore examined GMR expression on other mature and activated B-cell types. These studies indicated that the GMR expression of HCs is likely to reflect their late stage of B-cell development rather than their intrinsic activation. Thus, CLL, PLL, and normal circulating B cells all lacked GMR, while normal and myelomatous plasma cells possessed the receptor. Furthermore, both resting and activated (both in vivo and in vitro) tonsil B cells lacked GMR.
We next examined potential functions of the GMR on HCs in relation to what is known for myeloid ~e l l s .~. '~.~' .~~. "~~~~' GM-CSF had no effect on the proliferation or differentiation of HCs, even when tested in combination with factors known to influence these functions. Furthermore, the cytokine did not influence the survival of HCs in vitro.
We have recently shown that M-CSF stimulates HCs motility without affecting proliferation or differentiati~n.~'~~~ This prompted us to investigate the effects of GM-CSF on HC motility. To do this, we examined the effect of the cytokine on HCs stimulated to become motile by interaction with ~itronectin.'~ GM-CSF caused a dramatic change in the appearance of the cells such that they became nonpolar, rounded, and detached from the vitronectin substratum; the changes were confirmed objectively by image analysis. These observations prompted us to look at the effects of GM-CSF on HC chemokinesis/chemotaxis and adhesion. The cytokine was clearly not chemotactic and inhibited chemokinesis. Regarding adhesion, GM-CSF caused HCs adherent to fibronectin to round up and detach. This antiadhesive effect of the cytokine was confirmed in formal adhesion assays of HCs adherent to vitronectin or fibronectin. The experiments with endothelial cells43 also suggested an antiadhesive effect of GM-CSF on HCs (although an effect of the cytokine on endothelial cells was not excluded by our experimental design). These effects differ from those of the cytokine on other cell types, where both motility and adhesion are generally Finally, we investigated the mechanism(s) of these antimotility/adhesion effects. We first considered the relevant integrins; avp3 is involved in HC while cu4/a5Pl and a M h X P 2 are important in interactions with fibronec- tin2' and endothelium?' We clearly showed that levels of expression of these integrins were not affected by exposure to GM-CSF. Next, because the observed effects of the cytokine on HCs all involved the cytoskeleton, we examined the effect of GM-CSF on actin polymerization. Rapid changes in F-actin were demonstrated, indicating cytoskeletal reorganization. We therefore conclude that the effects of GM-CSF are mediated by the induction of cytoskeletal changes, although cytokine-induced changes in integrin function, independent of levels of expression, cannot be ruled o~t . 4~
Our previous work has indicated that the migratiodlocalization of HCs into and within tissues is influenced by both integridextracellular matrix interactions and local cytokine a~t i v i t y .~~, '~ For example, we have shown that M-CSF stimulates the migration of HCs on vitronectin. The present findings indicate that GM-CSF has the opposite effect. Thus, the tissue migratiodlocalization of HCs is under both positive and negative control by cytokines. Many of the characteristics of HCs do not reflect their malignant nature, but rather are shared by normal activated B cells of a comparable stage of differentiati~n.~~.~~,~~~' It seems likely, therefore, that the present findings indicate that myeloid growth factors act in concert to facilitate the controlled migration of certain B cells into and within tissues.
Finally, the present results may have therapeutic relevance, as GM-CSF is currently being used in lymphoproliferative disorders and myeloma to rescue patients from chemotherapy-induced cytopenia. For personal use only. on April 10, 2017. by guest www.bloodjournal.org From
